The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. The IMP is located at the Vienna BioCenter, one of Europe’s most dynamic life science hubs with 2,800 employees from 78 countries in six research institutes, three universities and 40 biotech companies.
Research Institute for Molecular Pathology
Campus-Vienna-Biocenter 1
1030 Vienna
Austria
Vienna BioCenter
Campus-Vienna-Biocenter 1
1030 Vienna
Austria